ADHD diagnosis in adults appears to vary substantially depending on how and where the evaluation is done — with some pathways more likely to over-identify and others more likely to miss genuine cases. Dr. Margarita Krasnova has reviewed 80 published studies on this question; the overall evidence is limited, but it consistently points toward structured, multi-step assessment as the more reliable approach.
Direct Answer
ADHD diagnosis in adults is a well-established clinical practice — validated assessment tools and structured interviews have been developed over decades, and a careful, structured evaluation can meaningfully distinguish ADHD from other conditions in many cases. The narrower question this review examined is whether the diagnostic practices currently in wide use are consistently accurate, and here the evidence tells a more complicated story.
Based on a review of 80 studies, it appears that adult ADHD is simultaneously over-identified in some clinical pathways and under-identified in others. The direction of the error depends heavily on who is being evaluated, in what setting, and with what tools. Brief self-report questionnaires, when used on their own, tend to flag far more people as probable ADHD cases than a more thorough evaluation would confirm. Conversely, women, adults with prominent anxiety or depression, and individuals in substance-use or criminal-justice settings appear to be recognized less often than the research suggests they should be. Because the available studies are varied in design, mostly conducted in specialized settings, and generally rated as low-certainty evidence overall, these findings should be understood as an honest map of where the field stands — not as a definitive verdict.
What earlier understanding suggested
For much of the past three decades, adult ADHD was treated primarily as a condition affecting men, and the main diagnostic concern was over-identification — particularly the idea that stimulant medications were being dispensed too freely. Earlier evidence pointed toward self-report screening as a reasonable way to identify potential cases, and brief clinical assessments were widely used in practice. Based on the research available at the time, clinicians reasonably developed systems that prioritized sensitivity — catching possible cases — over the more resource-intensive process of multi-step, multi-informant evaluation. That approach reflected the state of the evidence then, and it helped many adults who had been missed in childhood receive care.
What recent evidence suggests
Dr. Krasnova reviewed 80 studies on this question, covering research published from 2023 through 2026.
The most consistent finding across these studies is that brief self-report questionnaires — the kind routinely used for initial screening — identify far more adults as likely to have ADHD than a thorough diagnostic evaluation actually confirms. In one stepwise study of medical students, self-report screening identified about 37% as probable ADHD cases; a semi-structured clinical interview brought that number down to roughly 8%; and then probing for real-world examples of those symptoms in daily life reduced it further, to about 4.5%. Across primary care settings, screening positive rates of 30% or more were reported in populations where the actual prevalence is estimated at 2–7%.
On the other side, the evidence also shows groups where ADHD goes systematically unrecognized. Women in large clinical samples were diagnosed significantly later than men, with greater severity and more pronounced disability at the time they finally received a diagnosis. Adults presenting primarily with anxiety were found to have ADHD rates of nearly 28%, well above general population estimates. In criminal-justice and substance-use treatment settings, structured screening identified many individuals without prior diagnoses as warranting further evaluation.
Structured diagnostic interviews — particularly tools called the DIVA 2.0 and DIVA-5 — performed considerably better than brief self-report alone, with diagnostic accuracy above 90% in at least two specialist-setting validation studies. These figures come from specialist validation settings and may not transfer directly to all clinical contexts. When structured interviews were combined with collateral information (input from someone who knows the patient well) and measures of real-world functioning, classification accuracy improved substantially. Neuropsychological testing alone, by contrast, was found to perform poorly.
Retrospective recall of childhood symptoms — which is typically a required part of an adult ADHD evaluation — proved unreliable: in one longitudinal study, 79% of adults underreported their own childhood symptoms compared to parent ratings collected during childhood. Dedicated tests designed to detect symptom exaggeration found evidence of non-credible reporting in a significant proportion of self-referred individuals, particularly in college populations.
This is a narrow question about diagnostic accuracy in specific assessment pathways — not a verdict on whether ADHD treatment helps adults broadly.
The studies in this review were largely cross-sectional (single-point-in-time), conducted in specialized settings, and rated as very low certainty overall, which limits the confidence with which any firm conclusions can be drawn.
What this means in practice
For most adults seeking an ADHD evaluation, what this research suggests is that the thoroughness of the evaluation matters considerably. A brief questionnaire followed by a short clinical conversation gives a different — and often less reliable — picture than a structured clinical interview, collateral input from someone who knows the patient well, and documentation of real-world impairment. If you have completed an ADHD evaluation and have questions about whether the process was thorough enough, that is a reasonable conversation to have with the clinician who conducted it or with a specialist.
For adults who have not been evaluated but wonder whether ADHD could explain longstanding difficulties — particularly women, adults whose primary symptoms are inattention rather than hyperactivity, or adults with significant anxiety or depression — it may be worth raising with a clinician: the evidence suggests these groups are frequently underrecognized.
A diagnosis should not be made — or dismissed — based on a single questionnaire. Most screening tools are designed to identify people who may benefit from further evaluation, not to provide a definitive answer by themselves.
In my own practice, when a patient asks me about adult ADHD — whether questioning a prior diagnosis or wondering if they should be evaluated — I try to understand how the evaluation was performed and whether important pieces of the picture may still be missing. A well-structured assessment includes more than a checklist: it involves exploring the history of symptoms across settings, reviewing how those symptoms affect daily functioning, and, where possible, getting input from someone who knows the patient well. The evidence on this question is limited enough that I hold my conclusions with some humility, and I think the research supports that humility — there is no quick test that settles this definitively.
What this is and isn't
This is general educational information based on a structured review of recent medical evidence. It is not a substitute for personalized medical advice. Your individual situation may differ; consult your physician for guidance specific to you.
This summary draws on 80 published studies covering research from 1999–2026. Full source breakdown and methodology are in the linked Evidence Review.
If you'd like to discuss how this might apply to your own situation, that is a conversation worth having with a physician who knows you.
Contact Dr. Krasnova →